Townson Sharon 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Townson Sharon（CIK 1855689）在 1 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-07-07）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-07 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 买入 | 6,000 | $36,840 |
| 2026-07-07 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 卖出 | 5,600 | $130,197 |
| 2026-07-07 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 卖出 | 400 | $9,652 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 买入 | 3,000 | $18,420 |
| 2026-06-25 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 卖出 | 3,000 | $60,000 |
| 2026-06-18 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 买入 | 3,000 | $18,420 |
| 2026-06-18 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 卖出 | 3,000 | $57,000 |
| 2026-06-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 买入 | 6,000 | $36,840 |
| 2026-06-01 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 卖出 | 6,000 | $119,220 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 买入 | 35,000 | $0 |
| 2026-01-05 | Monte Rosa Therapeutics, Inc. (GLUE) | Chief Scientific Officer | 卖出 | 3,155 | $47,861 |
来源：SEC Form 4 申报文件 · 截至 2026-07-07